Multimodal MRI-based Detection of Amyloid Status in Alzheimer's Disease Continuum
- URL: http://arxiv.org/abs/2406.13305v1
- Date: Wed, 19 Jun 2024 07:51:21 GMT
- Title: Multimodal MRI-based Detection of Amyloid Status in Alzheimer's Disease Continuum
- Authors: Giorgio Dolci, Charles A. Ellis, Federica Cruciani, Lorenza Brusini, Anees Abrol, Ilaria Boscolo Galazzo, Gloria Menegaz, Vince D. Calhoun,
- Abstract summary: Amyloid-$beta$ plaques are neuropathological hallmarks of Alzheimer's disease (AD)
Deep learning methods relying mainly on amyloid PET images have been employed to this end.
We propose a novel multimodal approach that integrates information from structural, functional, and diffusion MRI data to discriminate A$beta$ status in the AD continuum.
- Score: 13.220436208437576
- License: http://creativecommons.org/licenses/by/4.0/
- Abstract: Amyloid-$\beta$ (A$\beta$) plaques in conjunction with hyperphosphorylated tau proteins in the form of neurofibrillary tangles are the two neuropathological hallmarks of Alzheimer's disease (AD). In particular, the accumulation of A$\beta$ plaques, as evinced by the A/T/N (amyloid/tau/neurodegeneration) framework, marks the initial stage. Thus, the identification of individuals with A$\beta$ positivity could enable early diagnosis and potentially lead to more effective interventions. Deep learning methods relying mainly on amyloid PET images have been employed to this end. However, PET imaging has some disadvantages, including the need of radiotracers and expensive acquisitions. Hence, in this work, we propose a novel multimodal approach that integrates information from structural, functional, and diffusion MRI data to discriminate A$\beta$ status in the AD continuum. Our method achieved an accuracy of $0.762\pm0.04$. Furthermore, a \textit{post-hoc} explainability analysis (guided backpropagation) was performed to retrieve the brain regions that most influenced the model predictions. This analysis identified some key regions that were common across modalities, some of which were well-established AD-discriminative biomarkers and related to A$\beta$ deposition, such as the hippocampus, thalamus, precuneus, and cingulate gyrus. Hence, our study demonstrates the potential viability of MRI-based characterization of A$\beta$ status, paving the way for further research in this domain.
Related papers
- AXIAL: Attention-based eXplainability for Interpretable Alzheimer's Localized Diagnosis using 2D CNNs on 3D MRI brain scans [45.630166504856255]
This study presents an innovative method for Alzheimer's disease diagnosis using 3D MRI designed to enhance the explainability of model decisions.
Our approach adopts a soft attention mechanism, enabling 2D CNNs to extract volumetric representations.
With voxel-level precision, our method identified which specific areas are being paid attention to, identifying these predominant brain regions.
arXiv Detail & Related papers (2024-07-02T16:44:00Z) - An interpretable generative multimodal neuroimaging-genomics framework for decoding Alzheimer's disease [13.213387075528017]
Alzheimer's disease (AD) is the most prevalent form of dementia with a progressive decline in cognitive abilities.
In this study, we leveraged structural and functional MRI to investigate the disease-induced grey matter and functional network connectivity changes.
We propose a novel deep learning-based classification framework where generative module employing Cycle GANs was adopted to impute missing data within the latent space.
arXiv Detail & Related papers (2024-06-19T07:31:47Z) - Vision Transformers and Bi-LSTM for Alzheimer's Disease Diagnosis from
3D MRI [0.0]
Alzheimer's disease (AD) can be treated and managed if it is diagnosed early.
In this study, we suggested using the Visual Transformer (ViT) and bi-LSTM to process MRI images for diagnosing Alzheimer's disease.
The proposed method performs well in terms of accuracy, precision, F-score, and recall for the diagnosis of AD.
arXiv Detail & Related papers (2024-01-06T06:11:03Z) - A Surface-Based Federated Chow Test Model for Integrating APOE Status,
Tau Deposition Measure, and Hippocampal Surface Morphometry [18.36168858563601]
Alzheimer's Disease (AD) is the most common type of age-related dementia, affecting 6.2 million people aged 65 or older according to CDC data.
It is commonly agreed that discovering an effective AD diagnosis biomarker could have enormous public health benefits.
arXiv Detail & Related papers (2023-03-31T21:17:54Z) - Improved Prediction of Beta-Amyloid and Tau Burden Using Hippocampal
Surface Multivariate Morphometry Statistics and Sparse Coding [0.0]
We develop a non-invasive framework to quantitatively predict the amyloid and tau measurements.
We evaluate our framework on amyloid PET/MRI and tau PET/MRI datasets from the Alzheimer's Disease Neuroimaging Initiative (ADNI)
arXiv Detail & Related papers (2022-10-28T03:39:55Z) - Predicting Tau Accumulation in Cerebral Cortex with Multivariate MRI
Morphometry Measurements, Sparse Coding, and Correntropy [18.81651314175103]
One of the hallmarks of Alzheimer's disease (AD) is the accumulation of tau plaques in the human brain.
Current methods to detect tau pathology are either invasive (lumbar puncture) or quite costly and not widely available (Tau PET)
arXiv Detail & Related papers (2021-10-20T18:05:33Z) - Automatic Assessment of Alzheimer's Disease Diagnosis Based on Deep
Learning Techniques [111.165389441988]
This work is to develop a system that automatically detects the presence of the disease in sagittal magnetic resonance images (MRI)
Although sagittal-plane MRIs are not commonly used, this work proved that they were, at least, as effective as MRI from other planes at identifying AD in early stages.
This study proved that DL models could be built in these fields, whereas TL is an essential tool for completing the task with fewer examples.
arXiv Detail & Related papers (2021-05-18T11:37:57Z) - G-MIND: An End-to-End Multimodal Imaging-Genetics Framework for
Biomarker Identification and Disease Classification [49.53651166356737]
We propose a novel deep neural network architecture to integrate imaging and genetics data, as guided by diagnosis, that provides interpretable biomarkers.
We have evaluated our model on a population study of schizophrenia that includes two functional MRI (fMRI) paradigms and Single Nucleotide Polymorphism (SNP) data.
arXiv Detail & Related papers (2021-01-27T19:28:04Z) - A Graph Gaussian Embedding Method for Predicting Alzheimer's Disease
Progression with MEG Brain Networks [59.15734147867412]
Characterizing the subtle changes of functional brain networks associated with Alzheimer's disease (AD) is important for early diagnosis and prediction of disease progression.
We developed a new deep learning method, termed multiple graph Gaussian embedding model (MG2G)
We used MG2G to detect the intrinsic latent dimensionality of MEG brain networks, predict the progression of patients with mild cognitive impairment (MCI) to AD, and identify brain regions with network alterations related to MCI.
arXiv Detail & Related papers (2020-05-08T02:29:24Z) - Detecting Parkinsonian Tremor from IMU Data Collected In-The-Wild using
Deep Multiple-Instance Learning [59.74684475991192]
Parkinson's Disease (PD) is a slowly evolving neuro-logical disease that affects about 1% of the population above 60 years old.
PD symptoms include tremor, rigidity and braykinesia.
We present a method for automatically identifying tremorous episodes related to PD, based on IMU signals captured via a smartphone device.
arXiv Detail & Related papers (2020-05-06T09:02:30Z) - Segmentation for Classification of Screening Pancreatic Neuroendocrine
Tumors [72.65802386845002]
This work presents comprehensive results to detect in the early stage the pancreatic neuroendocrine tumors (PNETs) in abdominal CT scans.
To the best of our knowledge, this task has not been studied before as a computational task.
Our approach outperforms state-of-the-art segmentation networks and achieves a sensitivity of $89.47%$ at a specificity of $81.08%$.
arXiv Detail & Related papers (2020-04-04T21:21:44Z)
This list is automatically generated from the titles and abstracts of the papers in this site.
This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.